Real-world experience supporting the role of oncologic resection and adjuvant chemotherapy in biliary tract cancers
Background: Complete resection followed by adjuvant chemotherapy is the gold standard for patients with localized cholangiocarcinoma (CC) or gallbladder cancer (GBC). However, this is not always feasible, and recurrence rates remain high. Objectives: To understand the real-world proportions and reas...
Main Authors: | Melina Boutin, Tharani Krishnan, Maria Safro, Jenny Yang, Helia Jafari, Janine M. Davies, Sharlene Gill |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-04-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359241247008 |
Similar Items
-
Adjuvant treatment after resection of biliary-tract cancer: yes or no?
by: Eveline Boucher, et al.
Published: (2011-12-01) -
The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis
by: Yoichi Miyata, et al.
Published: (2021-03-01) -
Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience
by: Kentaro Iwaki, et al.
Published: (2024-03-01) -
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
by: Yueting Zhu, et al.
Published: (2023-09-01) -
Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma
by: Yunfeng Li, et al.
Published: (2023-08-01)